CardioMEMS Shows Promise for Expanded Use Despite Falling Short in Trial

By Kate Buron When The U.S. Food and Drug Administration (FDA) approved the CardioMEMS HF System in 2014, Abbott harnessed the power of artificial intelligence (AI) coupled with telemedicine for managing patients with heart failure (HF). Expanded use of the system was the objective of a new trial initiated in 2018, but the onset of […]

Using Artificial Intelligence to Predict CV Risk Assessment

It is well-established that patients with the highest proportion of visceral fat area are more likely to experience a heart attack or other cardiovascular event. While abdominal CT scans can provide a more granular look at body composition when routinely performed, ascertaining risk levels based on fat area is rarely done in clinical practice. Manually […]

Growth Seen in Artificial Intelligence-Based Nutrition

Decades of nutritional fads, ranging from the Atkins diet to the more recently popularized ketogenic diet, have lulled us into a false sense of belief in a universal diet: with collective benefits applicable to each and every participant. Yet with the development of innovative research methods and newly available technology, commonly accepted ideas in the […]

Artificial Intelligence in Precision Cardiovascular Medicine

The rapidly growing field of Artificial Intelligence (AI)—a field of computer science that seeks to perform and directly mimic tasks that generally require human intelligence—has developed a series of techniques that have been applied in cardiovascular medicine. Designed to enhance patient care, improve cost-effectiveness, and reduce readmission and mortality rates, these machine-learning techniques have been […]